当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析

普洛药业

(000739)

  

流通市值:177.64亿  总市值:177.71亿
流通股本:11.58亿   总股本:11.58亿

普洛药业(000739)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润7.00亿元,每股收益0.61元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益649419.27万元,未分配利润497590.61万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1210196.28万元,负债560777.01万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入7,763,882,133.275,444,486,087.312,730,189,121.9712,021,863,029.21
营业总成本6,996,741,278.284,838,162,638.12,490,659,565.2810,858,989,886.75
其他经营收益
营业利润842,655,816.16660,249,384.93298,437,200.121,212,070,903.26
利润总额839,139,546.78658,587,798.37297,471,282.941,203,290,373.01
净利润700,189,009.91563,071,412.09248,576,261.581,030,846,722.3
每股收益
其他综合收益937,413.11318,525.6391,753.6610,713,506.8
综合收益总额701,126,423.02563,389,937.72248,668,015.241,041,560,229.1
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计7,585,032,315.138,011,650,969.638,228,646,015.778,186,761,774.66
非流动资产:
非流动资产合计4,516,930,484.214,471,960,429.194,479,894,940.954,542,246,835.5
资产总计12,101,962,799.3412,483,611,398.8212,708,540,956.7212,729,008,610.16
流动负债:
流动负债合计5,316,853,533.245,382,021,923.245,466,974,634.365,742,629,852.13
非流动负债:
非流动负债合计290,916,547.6345,083,373.18243,015,127.4236,495,578.31
负债合计5,607,770,080.845,727,105,296.425,709,989,761.765,979,125,430.44
所有者权益(或股东权益):
归属于母公司股东权益合计6,486,351,400.776,748,563,568.946,990,603,683.936,741,964,785.16
股东权益合计6,494,192,718.56,756,506,102.46,998,551,194.966,749,883,179.72
负债和股东权益合计12,101,962,799.3412,483,611,398.8212,708,540,956.7212,729,008,610.16
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计6,293,882,351.314,128,407,073.222,227,671,600.3910,411,469,786.97
经营活动现金流出小计5,519,858,244.643,721,226,512.92,242,665,069.559,202,716,103.96
经营活动产生的现金流量净额774,024,106.67407,180,560.32-14,993,469.161,208,753,683.01
投资活动产生的现金流量:
投资活动现金流入小计986,330,907.92543,989,471.66271,293,102.69898,626,068.92
投资活动现金流出小计1,224,656,435.27672,733,223.93362,663,790.841,296,637,801.32
投资活动产生的现金流量净额-238,325,527.35-128,743,752.27-91,370,688.15-398,011,732.4
筹资活动产生的现金流量:
筹资活动现金流入小计1,620,900,0001,062,900,000296,900,0001,388,885,064.79
筹资活动现金流出小计2,190,685,623.071,283,559,126.65328,296,306.271,971,036,445.91
筹资活动产生的现金流量净额-569,785,623.07-220,659,126.65-31,396,306.27-582,151,381.12
汇率变动对现金及现金等价物的影响3,355,523.377,432,261.763,246,242.9338,368,228.83
现金及现金等价物净增加额-30,731,520.3865,209,943.16-134,514,220.65266,958,798.32
期末现金及现金等价物余额2,698,713,039.682,794,654,503.222,594,930,339.412,729,444,560.06
补充资料:
现金及现金等价物的净增加额-65,209,943.16-266,958,798.32
最新报告期:2025-10-23
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
开源证券阮帅,余汝意0.781.031.292025-10-23
信达证券唐爱金0.931.111.312025-08-26
中泰证券祝嘉琦0.961.091.252025-08-26
开源证券阮帅,余汝意1.021.191.432025-08-21
财通证券邹一瑜0.881.051.262025-08-21
TOP↑